Valuation: Feedback plc

Market Cap 3.11M 4.12M 3.61M 3.33M 5.85M 390M 5.96M 40M 15.5M 192M 15.48M 15.15M 671M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.13M 1.5M 1.31M 1.21M 2.12M 142M 2.16M 14.52M 5.63M 69.88M 5.62M 5.5M 243M EV / Sales 2026 *
1.39x
EV / Sales 2027 * 4.97x
Free-Float
94.44%
Yield 2026 *
-
Yield 2027 * -
1 week-2.74%
Current month-12.35%
1 month-12.35%
3 months-45.38%
6 months-25.26%
Current year-26.23%
1 week 7
Extreme 7
7.5
1 month 7
Extreme 7
8.01
Current year 7
Extreme 7
15
1 year 7
Extreme 7
15
3 years 7
Extreme 7
152.92
5 years 7
Extreme 7
274.8
10 years 7
Extreme 7
1,040
Manager TitleAgeSince
Chief Executive Officer 38 09/04/2019
Director of Finance/CFO 54 10/11/2025
Compliance Officer 56 01/02/2001
Director TitleAgeSince
Director/Board Member 38 09/04/2019
Chairman 72 18/11/2019
Director/Board Member 55 03/02/2020
Date Insider Type Main position Quantity % Market Cap.
23/12Buy

Chief Financial Officer

60,549 0.1382%
23/12Buy

Chief Executive Officer

60,904 0.1390%
10/07/25Free

Public Communications Manager

219,073 0.5000%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-2.74%-50.18%-93.33% 4.12M
+0.71%+15.87%-37.38%-9.06% 28.63B
+3.03%+16.49%-27.50%+206.00% 14.19B
+0.88%+0.22%-20.12%+51.82% 5.4B
-15.81%-13.30% - - 3.01B
-0.24%+6.17% - - 2.17B
+1.47%+7.34%+41.32%-43.13% 1.86B
+1.95%+4.23%-24.96% - 1.3B
+2.23%+5.47%-32.62%+236.91% 758M
-0.31%-6.98%-43.76%-61.49% 731M
Average -0.61%+4.14%-24.40%+41.10% 5.8B
Weighted average by Cap. +0.46%+11.18%-29.91%+58.14%

Financials

2026 *2027 *
Net sales 810K 1.07M 940K 868K 1.52M 102M 1.55M 10.42M 4.04M 50.12M 4.03M 3.94M 175M 810K 1.07M 940K 868K 1.52M 102M 1.55M 10.42M 4.04M 50.12M 4.03M 3.94M 175M
Net income - -
Net Debt -1.98M -2.63M -2.3M -2.12M -3.73M -249M -3.8M -25.48M -9.87M -123M -9.86M -9.65M -427M 914K 1.21M 1.06M 979K 1.72M 115M 1.75M 11.75M 4.55M 56.56M 4.55M 4.45M 197M
Logo Feedback plc
Feedback plc is a United Kingdom-based clinical infrastructure specialist. The Company designs products that enhance clinician access to patient data and to their colleagues. The Company's approach centers around individual patient episodes, into which it pulls relevant clinical data from hospital systems and around which it builds remote clinical teams for collaboration. The Company’s segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa and CareLocker. Bleepa is its application layer and sits on top of CareLocker as its data layer. Bleepa is its communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multidisciplinary team working and diagnostic-enhanced advice and guidance. CareLocker is its patient-facing platform that gives patients access and control over their diagnostic and other clinical data.
Employees
29
Date Price Change Volume
30/06/26 GBX 7.100 -.--% 1,249
29/06/26 GBX 7.100 -.--% 378
26/06/26 GBX 7.100 -.--% 19,690
25/06/26 GBX 7.100 -.--% 522
24/06/26 GBX 7.100 -2.74% 25,225
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0710GBP
Average target price
0.6000GBP
Spread / Average Target
+745.07%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FDBK Stock